研究者業績

浜谷 敏生

ハマタニ トシオ  (Hamatani Toshio)

基本情報

所属
藤田医科大学 臨床再生医学 教授

通称等の別名
藤田医科大学東京 先端医療研究センター 羽田クリニック・リプロダクションセンター
研究者番号
60265882
J-GLOBAL ID
200901079698132110
researchmap会員ID
1000228127

学歴

 2

論文

 141
  • Akiko Takashima, Yukihiro Shibui, Toshio Hamatani, Akihiko Suenaga, Yoshimitsu Kuwabara, Fuminori Kimura, Koji Nakagawa, Yusuke Fukuda, Shoji Tokunaga, Yukiko Katagiri
    Journal of Obstetrics and Gynaecology Research 51(6) 2025年6月2日  
    Abstract Aim Progesterone has to be administered to prepare the endometrium for frozen–thawed blastocyst transfer (FBT) in a hormone replacement cycle (HRC). The objective of this study was to investigate the efficacy and safety of using Crinone® progesterone gel alone in HRC‐FBT. Methods In this multicenter prospective study, HRC‐FBT was performed with blastocysts with a Gardner's classification of 3BB or better, and application of 90 mg/day of vaginal gel (Crinone, Merck BioPharma, Tokyo) was started when the endometrial thickness reached 8 mm or more. The primary endpoint was the clinical pregnancy rate (CPR). Safety endpoints included genital bleeding and other adverse events. Recruitment started in May 2018. Results A total of 181 patients were enrolled, and 156 were included in the efficacy analysis. The overall CPR was 41.7% (65/156). In patients younger than 38 years (n = 113), the CPR was 48.7% (55/113), and in those aged 38 years or older (n = 43), it was 23.3% (10/43). The overall CPR was comparable to that observed in the Japan Society of Obstetrics and Gynecology ART2020 National Survey, which reported a pregnancy rate of 36.3% in frozen embryo transfer cycles. Adverse events such as light genital bleeding occurred before and after pregnancy in some patients, but at a low frequency (<10%). Conclusions Use of Crinone progesterone vaginal gel alone is adequate in HRC‐FBT and is not associated with any safety issues.
  • 田中 宏明, 小田 佳奈子, 山中 紋奈, 小島 淳哉, 小野 政徳, 山田 満稔, 浜谷 敏生, 田中 守, 笹岡 俊邦, 西 洋孝, 久慈 直昭
    日本生殖医学会雑誌 68(4) 488-488 2023年10月  
  • Saito S, Yamada M, Yano R, Takahashi K, Ebara A, Sakanaka H, Matsumoto M, Ishimaru T, Utsuno H, Matsuzawa Y, Ooka R, Fukuoka M, Akashi K, Kamijo S, Hamatani T, Tanaka M
    J Ovarian Res 16(1) 159 2023年8月  
  • 佐久間萌子, 山田満稔, 松沢優一, 大岡令奈, 福岡美桜, 宮崎康太郎, 木村寛子, 上條慎太郎, 浜谷敏生, 青木大輔, 田中守
    東京産科婦人科学会会誌 72(4) 752-757 2023年  査読有り
  • 浜谷敏生, 宇津野宏樹, 木村寛子, 宮崎康太郎, 福岡美桜, 田中守
    臨床検査 67(1) 58-63 2023年1月  筆頭著者責任著者
  • Yukiko Katagiri, Seung Chik Jwa, Akira Kuwahara, Takeshi Iwasa, Masanori Ono, Keiichi Kato, Hiroshi Kishi, Yoshimitsu Kuwabara, Miyuki Harada, Toshio Hamatani, Yutaka Osuga
    Reproductive Medicine and Biology 22(1) 2023年  
  • Hiroaki Komatsu, Satoshi Nakagawa, Wataru Yamagami, Hideto Yamada, Susumu Miyashita, Kiyoshi Yoshino, Kei Kawana, Hiroaki Shibahara, Toshio Hamatani, Daisuke Aoki
    The journal of obstetrics and gynaecology research 49(1) 314-320 2023年1月  査読有り
    AIM: This study aimed to clarify the impact of coronavirus disease 2019 on gynecology practice in Japan, in particular, on surgeries for benign gynecological diseases. METHODS: An online questionnaire was distributed to 966 facilities in Japan, including core facilities, facilities participating in perinatal and gynecologic oncology registries, and facilities certified for training by the Japanese Society of Obstetrics and Gynecology Endoscopy. The number of surgeries performed was compared between 2019 and 2020, when the novel coronavirus disease was prevalent. RESULTS: Five hundred and eighty (58.2%) facilities responded. The total number of surgeries decreased from 129 648 in 2019 to 118 565 in 2020, by 8.5%, for all surgical procedures. However, there was a clear increase in the number of robotic surgeries performed in 2020 compared to that in 2019 for all populations. The number of total hysterectomies decreased markedly from 15 385 in 2019 to 12 531 in 2020, a fall of 10.1%. CONCLUSIONS: The number of surgeries for benign gynecological diseases decreased by 8.5% in 2020 compared to that in 2019. This value is among the lowest in the world.
  • Youki Takezawa, Maki Iwai, Yukiko Fujiki, Ryo Yokomizo, Harue Kishigami, Mami Miyado, Natsuko Kawano, Mitsutoshi Yamada, Miyuki Shindo, Miki Suzuki, Ban Sato, Daiki Katano, Shintaro Kamijo, Toshio Hamatani, Mamoru Tanaka, Akihiro Umezawa, Woojin Kang, Kenji Miyado
    Laboratory Investigation 100026-100026 2023年1月  査読有り
  • Shintaro Kamijo, Toshio Hamatani, Hiroyuki Sasaki, Hiroki Suzuki, Akane Abe, Osamu Inoue, Maki Iwai, Seiji Ogawa, Kei Odawara, Kanako Tanaka, Mutsumi Mikashima, Masami Suzuki, Kenji Miyado, Ryo Matoba, Yasushi Odawara, Mamoru Tanaka
    Reproductive Biology and Endocrinology 20(1) 2022年8月30日  
    Abstract Objective To generate an effective embryo prediction model and identify a non-invasive evaluation method by analyzing microRNAs (miRNAs) in embryo culture medium. Design Analysis of microRNA profiles from spent culture medium of blastocysts with good morphology that did or did not result in pregnancy. Setting Clinical and experimental research. Patients Sixty patients who underwent thawed embryo transfer of blastocysts after intracytoplasmic sperm injection. Intervention(s) None. Main outcome measure(s) The association of miRNA abundance levels secreted by blastocysts in culture medium and implantation success. Results Our RNA sequencing analysis found a total of 53 differentially expressed miRNAs in the culture media of pregnancy and non-pregnancy groups. Twenty-one miRNAs were analyzed for their potential to predict implantation success. Eight miRNAs (hsa-miR-191-5p, hsa-miR-320a, hsa-miR-92a-3p, hsa-miR-509-3p, hsa-miR-378a-3p, hsa-miR-28-3p, hsa-miR-512-5p, and hsa-miR-181a-5p) were further extracted from the results of a logistic regression analysis of qPCR Ct values. A prediction model for high-quality blastocysts was generated using the eight miRNAs, with an average accuracy of 0.82 by 5-fold cross validation. Conclusion We isolated blastocyst miRNAs that may predict implantation success and created a model to predict viable embryos. Increasing the number of investigated cases and further studying the effect of each miRNA on embryonic development is needed to refine the miRNA-based predictive model.
  • 吉政佑之, 浜谷敏生, 田中守
    臨床婦人科産科(2022年4月増大号) 【特集/最新の不妊症診療がわかる!―生殖補助医療を中心とした新たな治療体系】 6(4) 282-285 2022年4月  責任著者
  • Chisato Kunitomi, Miyuki Harada, Yuko Sanada, Akari Kusamoto, Yasushi Takai, Tatsuro Furui, Yuko Kitagawa, Mitsutoshi Yamada, Chie Watanabe, Koichiro Tsugawa, Hiroyuki Nishiyama, Hajime Hosoi, Mitsuru Miyachi, Kazuhiko Sugiyama, Yoshinobu Maeda, Akira Kawai, Toshio Hamatani, Keishi Fujio, Nao Suzuki, Yutaka Osuga
    Reproductive medicine and biology 21(1) e12453 2022年  
    PURPOSE: In 2017, the first guidelines for fertility preservation in cancer patients were published in Japan. However, the impact of the guidelines remains unknown. Therefore, the authors conducted a nationwide survey on cryopreservation procedures in the period from shortly before to after publication of the guidelines (2016-2019) and compared the results with our previous survey (2011-2015). The authors also surveyed reproductive specialists' awareness of the guidelines and implementation problems. METHODS: The authors sent a questionnaire to 618 assisted reproductive technology facilities certified by the Japanese Society of Obstetrics and Gynecology. RESULTS: The authors received responses from 395 institutions (63.8%). Among them, 144 institutions conducted cryopreservation for cancer patients (vs. 126 in 2011-2015) and performed 2537 embryo or oocyte and 178 ovarian tissue cryopreservation procedures (vs. 1085 and 122, respectively). Compared with the previous period, indications were more varied and protocols for controlled ovarian stimulation were more standardized. Reproductive specialists' interest in oncofertility was high, but many reported three main difficulties: selecting a treatment method, storing samples in the long term, and securing the necessary human resources. CONCLUSIONS: The practice of fertility preservation in cancer patients in Japan has been considerably affected by the first Japanese guidelines.
  • 内田 志穂, 水口 雄貴, 山田 満稔, 齋藤 早貴, 荘 慎太郎, 上條 慎太郎, 内田 明花, 内田 浩, 浜谷 敏生, 丸山 哲夫, 田中 守
    日本生殖医学会雑誌 66(3) 120-120 2021年7月  
  • 高畑 海音子, 佐藤 卓, 末岡 浩, 水口 雄貴, 上條 慎太郎, 山田 満稔, 浜谷 敏生, 田中 守, 青木 大輔
    東京産科婦人科学会会誌 70(2) 210-215 2021年4月  
  • 荘 慎太郎, 山田 満稔, 内田 浩, 内田 志穂, 齋藤 早貴, 上條 慎太郎, 水口 雄貴, 内田 明花, 浜谷 敏生, 丸山 哲夫, 田中 守
    日本生殖医学会雑誌 66(1-2) 74-74 2021年4月  
  • 上條 慎太郎, 浜谷 敏生, 山田 満稔, 小田原 靖, 田中 守, 青木 大輔
    日本産科婦人科学会雑誌 73(臨増) S-340 2021年3月  
  • 齋藤 早貴, 山田 満稔, 上條 慎太郎, 浜谷 敏生, 田中 守, 青木 大輔
    日本産科婦人科学会雑誌 73(臨増) S-594 2021年3月  
  • 國富 千智, 原田 美由紀, 山田 満稔, 浜谷 敏生, 古井 辰郎, 高井 泰, 鈴木 直, 大須賀 穣
    日本がん・生殖医療学会誌 4(1) 121-121 2021年2月  
  • 吉政佑之, 浜谷敏生, 宇津野宏樹, 上條慎太郎, 水口雄貴, 内田明花, 山田満稔, 内田浩, 丸山哲夫, 田中守
    GID(性同一性障害)学会雑誌 14(1) 121-128 2021年  査読有り責任著者
  • Ishihara O, Jwa S.C, Kuwahara A, Katagiri Y, Kuwabara Y, Hamatani T, Harada M, Osuga Y
    Reproductive Medicine and Biology 20(1) 3-12 2021年1月  
    Purpose: Since 2007, the Japan Society of Obstetrics and Gynecology (JSOG) has collected cycle-based data for assisted reproductive technology (ART) in an online registry. Here, we present the characteristics and treatment outcomes of ART cycles registered during 2018. Methods: The Japanese ART registry consists of cycle-specific information for all ART treatment cycles implemented at 621 participating facilities. We conducted descriptive analyses for such cycles registered for 2018. Results: In total, 454 893 treatment cycles and 56 979 neonates were reported in 2018: both increased from 2017. The mean maternal age was 38.0 years (standard deviation ± 4.7). Of 247 402 oocyte retrievals, 118 378 (47.8%) involved freeze-all-embryos cycles; fresh embryo transfer (ET) was performed in 50 463 cycles: a decreasing trend since 2015. A total of 199 914 frozen-thawed ET cycles were reported, resulting in 69 357 pregnancies and 49 360 neonates born. Single ET (SET) was performed in 82.2% of fresh transfers and 83.4% of frozen-thawed cycles, with singleton pregnancy/live birth rates of 97.2%/97.2% and 97.0%/97.2%, respectively. Conclusions: Total ART cycles and subsequent live births increased in 2018. SET was performed in over 80% of cases, and the mode of ET has shifted continuously from using fresh embryos to frozen-thawed ones compared with previous years.
  • 山上 亘, 上條 慎太郎, 吉村 拓馬, 平野 卓朗, 坂井 健良, 浜谷 敏生, 青木 大輔
    産婦人科の実際 69(13) 1645-1651 2020年12月  
  • 齋藤 早貴, 山田 満稔, 宇津野 宏樹, 石丸 智子, 松本 美保, 上條 慎太郎, 浜谷 敏生, 田中 守
    日本生殖医学会雑誌 65(4) 340-340 2020年11月  
  • Ichikawa T, Ota I, Kuwabara Y, Tsushima R, Hamatani T, Hiraike O, Takeshita T, Osuga Y, Akira S
    Journal of Obstetrics and Gynaecology Research 46(10) 1940-1950 2020年10月1日  
    Aim: Women undergoing infertility treatment often need to balance work and fertility treatment. Therefore, we evaluated the quality of life (QOL) and impact of infertility treatment on Japanese working women and their careers. Methods: We conducted an online questionnaire at 18 clinics in Japan. Responses were collected from 835 women, 713 of whom were working. The participants were divided into three groups based on treatment stage. Data were collected using the FertiQoL and an original questionnaire created by the authors. The Mann–Whitney U test and a multinomial logistic analysis were used. Results: Approximately 90% of the participants felt that treatment could hinder their work and 8% had quit their jobs. Low QOL was associated with sadness and despair due to infertility and mood disorders, disruptions to life and work, and the complicated medications and procedures involved in treatment. Social isolation and the effect of fertility treatment on daily life and work strongly hindered the careers of working women in the third stage of treatment (in vitro fertilization and intracytoplasmic sperm injection). Approximately 70% of the participants required support to subsidize treatment costs and sought shorter working hours and flextime systems. Only 55% informed their workplaces about the fertility treatment, but about 70% easily gained understanding by informing them. Conclusions: For many working women, infertility treatment posed barriers to their careers, which could explain the low QOL. Urgent introduction of a support system is necessary in Japan, and understanding and social acceptance of infertility appears to be important.
  • 中山 ロバート, 山田 満稔, 笠原 知樹, 関田 哲也, 中川 瑠美, 弘實 透, 山口 さやか, 浅野 尚文, 佐藤 卓, 浜谷 敏生, 田中 守, 中村 雅也, 松本 守雄
    日本整形外科学会雑誌 94(6) S1344-S1344 2020年7月  
  • 上條 慎太郎, 浜谷 敏生, 佐々木 拓幸, 祝井 麻希, 山田 満稔, 鈴木 寛規, 小田原 靖, 田中 守
    Journal of Mammalian Ova Research 37(1) S17-S17 2020年7月  
  • 祝井 麻希, 宮戸 健二, 原田 裕一郎, 浜谷 敏生, 上條 慎太郎, 山田 満稔, 田中 守, 青木 大輔
    日本産科婦人科学会雑誌 72(臨増) S-304 2020年3月  
  • Ishihara O, Jwa S.C, Kuwahara A, Katagiri Y, Kuwabara Y, Hamatani T, Harada M, Ichikawa T
    Reproductive Medicine and Biology 19(1) 3-12 2020年1月1日  
    Purpose: The Japan Society of Obstetrics and Gynecology (JSOG) has collected cycle-based assisted reproductive technology (ART) data in an online registry since 2007. Herein, we present the characteristics and treatment outcomes of ART cycles registered during 2017. Methods: We collected cycle-specific information for all ART cycles implemented at participating facilities and performed descriptive analysis. Results: In total, 448,210 treatment cycles and 56,617 neonates (1 in 16.7 neonates born in Japan) were reported in 2017, increased from 2016; the number of initiated fresh cycles decreased for the first time ever. The mean patient age was 38.0 years (standard deviation 4.6). A total 110,641 of 245,205 egg retrieval cycles (45.1%) were freeze-all cycles; fresh embryo transfer (ET) was performed in 55,720 cycles. A total 194,415 frozen-thawed ET cycles were reported, resulting in 66,881 pregnancies and 47,807 neonates born. Single ET (SET) was performed in 81.8% of fresh transfers and 83.4% of frozen cycles, with singleton pregnancy/live birth rates of 97.5%/97.3% and 96.7%/96.6%, respectively. Conclusions: Total ART cycles and subsequent live births increased continuously in 2017, whereas the number of initiated fresh cycles decreased. SET was performed in over 80% of cases, and ET shifted from using fresh embryos to frozen ones.
  • 春日 義史, 池ノ上 学, 西尾 浩, 仲村 勝, 落合 大吾, 岩田 卓, 田中 京子, 飛騨 麻里子, 浜谷 敏生, 宮越 敬, 勝又 徳子, 菊地 敦子, 田中 守, 青木 大輔
    日本周産期・新生児医学会雑誌 55(別冊) 32-33 2020年1月  
  • 祝井 麻希, 浜谷 敏生, 佐々木 拓幸, 上條 慎太郎, 小川 誠司, 山田 満稔, 宮戸 健二, 田中 守
    日本生殖医学会雑誌 64(4) 334-334 2019年10月  
  • 中山 ロバート, 笠原 知樹, 中川 瑠美, 関田 哲也, 弘實 透, 山口 さやか, 浅野 尚文, 佐藤 卓, 山田 満稔, 浜谷 敏生, 田中 守, 中村 雅也, 松本 守雄
    日本癌治療学会学術集会抄録集 57回 SY8-3 2019年10月  
  • Ogawa S, Yamada M, Nakamura A, Sugawara T, Nakamura A, Miyajima S, Harada Y, Ooka R, Okawa R, Miyauchi J, Tsumura H, Yoshimura Y, Miyado K, Akutsu H, Tanaka M, Umezawa A, Hamatani T
    Stem Cell Reports 12(6) 1366-1379 2019年6月11日  
    © 2019 The Authors Zygotic genome activation (ZGA) begins after fertilization and is essential for establishing pluripotency and genome stability. However, it is unclear how ZGA genes prevent mitotic errors. Here we show that knockout of the ZGA gene Zscan5b, which encodes a SCAN domain with C2H2 zinc fingers, causes a high incidence of chromosomal abnormalities in embryonic stem cells (ESCs), and leads to the development of early-stage cancers. After irradiation, Zscan5b-deficient ESCs displayed significantly increased levels of γ-H2AX despite increased expression of the DNA repair genes Rad51l3 and Bard. Re-expression of Zscan5b reduced γ-H2AX content, implying a role for Zscan5b in DNA damage repair processes. A co-immunoprecipitation analysis showed that Zscan5b bound to the linker histone H1, suggesting that Zscan5b may protect chromosomal architecture. Our report demonstrates that the ZGA gene Zscan5b is involved in genomic integrity and acts to promote DNA damage repair and regulate chromatin dynamics during mitosis. In this article, Yamada and colleagues show that Zscan5b deficiency increases DNA stress, compromises chromosomal structure during mitosis, and leads to the development of early-stage cancers. Zscan5b deficiency may offer a murine model of human chromosomal breakage syndromes.
  • Iwai M, Hamatani T, Nakamura A, Kawano N, Kanai S, Kang W, Yoshii N, Odawara Y, Yamada M, Miyamoto Y, Saito T, Saito H, Miyado M, Umezawa A, Miyado K, Tanaka M
    Laboratory Investigation 99(2) 200-209 2019年2月1日  
    © 2018, United States & Canadian Academy of Pathology. Tetraspanin CD9 is essential for sperm–egg fusion and also contributes to uterine repair through microexosome formation. Microexosomes share CD9 with exosomes and are released from eggs and uterine epithelial cells. However, the mechanism for the formation of microexosomes remains unknown. To address this issue, we examined membrane localization and extracellular release of CD9 proteins using uterine epithelial cells and secretions in mice and humans. In mice, CD9 localized predominantly on the basal region of the plasma membrane and relocated to the apical region upon embryo implantation. Furthermore, extracellular CD9 proteins were detected in uterine secretions of mice and women undergoing infertility treatment, but were below detectable levels in supernatants of pluripotent stem cells. Ultrastructural analysis demonstrated that membrane projections were shortened and the number of mitochondria was reduced in uterine epithelial cells lacking Cd9 genes. Our results suggest that CD9 repositioning and release affect both membrane structures and mitochondrial state in the uterus, and contribute to female fertility.
  • Hiroyuki Sasaki, Toshio Hamatani, Shintaro Kamijo, Maki Iwai, Masato Kobanawa, Seiji Ogawa, Kenji Miyado, Mamoru Tanaka
    Frontiers in endocrinology 10 811-811 2019年  責任著者
    Reproductive capacity in women starts to decline beyond their mid-30s and pregnancies in older women result in higher rates of miscarriage with aneuploidy. Age-related decline in fertility is strongly attributed to ovarian aging, diminished ovarian reserves, and decreased developmental competence of oocytes. In this review, we discuss the underlying mechanisms of age-related decline in oocyte quality, focusing on oxidative stress (OS) in oocytes. The primary cause is the accumulation of spontaneous damage to the mitochondria arising from increased reactive oxygen species (ROS) in oocytes, generated by the mitochondria themselves during daily biological metabolism. Mitochondrial dysfunction reduces ATP synthesis and influences the meiotic spindle assembly responsible for chromosomal segregation. Moreover, reproductively aged oocytes produce a decline in the fidelity of the protective mechanisms against ROS, namely the ROS-scavenging metabolism, repair of ROS-damaged DNA, and the proteasome and autophagy system for ROS-damaged proteins. Accordingly, increased ROS and increased vulnerability of oocytes to ROS lead to spindle instability, chromosomal abnormalities, telomere shortening, and reduced developmental competence of aged oocytes.
  • Iwai M, Harada Y, Miyabayashi R, Kang W, Nakamura A, Kawano N, Miyamoto Y, Yamada M, Hamatani T, Miyado M, Yoshida K, Saito H, Tanaka M, Umezawa A, Miyado K
    Heliyon 4(11) e00944 2018年11月  
    © 2018 The Authors Mitochondria are the powerhouses of eukaryotic cells and their positioning contributes to fertilization and early developmental processes. We report that sperm fusion triggers Ca2+ oscillations and mitochondrial movement toward fused sperm (mitochondrial chemotaxis) in mouse eggs. Mitochondria functioned in Ca2+ storage and were colocalized with endoplasmic reticulum (ER) during Ca2+ oscillations. Mitochondria then moved toward the fused sperm. Sperm extracts lacking nuclei induced Ca2+ oscillations, but did not promote mitochondrial chemotaxis. Our results suggest that sperm fusion motivates Ca2+ oscillation-independent mitochondrial chemotaxis. This phenomenon indicates that egg mitochondria interact with sperm materials, presumably nuclear substances, and their network tethers egg and sperm nuclei at the early stage of zygote formation.
  • 浜谷 敏生
    Genes to Cells 23(10) 904-914 2018年10月  
    © 2018 Molecular Biology Society of Japan and John Wiley & Sons Australia, Ltd In bacteria, a polymer of inorganic phosphate (Pi) (inorganic polyphosphate; polyP) is enzymatically produced and consumed as an alternative phosphate donor for adenosine triphosphate (ATP) production to protect against nutrient starvation. In vertebrates, polyP has been dismissed as a “molecular fossil” due to the lack of any known physiological function. Here, we have explored its possible role by producing transgenic (TG) mice widely expressing Saccharomyces cerevisiae exopolyphosphatase 1 (ScPPX1), which catalyzes hydrolytic polyP degradation. TG mice were produced and displayed reduced mitochondrial respiration in muscles. In female TG mice, the blood concentration of lactic acid was enhanced, whereas ATP storage in liver and brain tissues was reduced significantly. Thus, we suggested that the elongation of polyP reduces the intracellular Pi concentration, suppresses anaerobic lactic acid production, and sustains mitochondrial respiration. Our results provide an insight into the physiological role of polyP in mammals, particularly in females.
  • Kang W, Ishida E, Yamatoya K, Nakamura A, Miyado M, Miyamoto Y, Iwai M, Tatsumi K, Saito T, Saito K, Kawano N, Hamatani T, Umezawa A, Miyado K, Saito H
    Biochemistry and Biophysics Reports 15 107-114 2018年9月  
    © 2018 The Authors Autophagic recycling of cell parts is generally termed as the opposite of cell death. Here, we explored the relation between cell death and autophagy by examining granulosa cell layers that control oocyte quality, which is important for the success of fertilization. Granulosa cell layers were collected from infertile women and morphologically divided into four types, viz., mature (MCCs), immature (ICCs), and dysmature cumulus cells (DCCs), and mural granulosa cells (MGCs). Microtubule-associated protein light chain 3 (LC3), which is involved in autophagosome formation, was expressed excessively in DCCs and MGCs, and their chromosomal DNA was highly fragmented. However, autophagy initiation was limited to MGCs, as indicated by the expression of membrane-bound LC3-II and autophagy-related protein 7 (ATG7), an enzyme that converts LC3-I to LC3-II. Although pro-LC3 was accumulated, autophagy was disabled in DCCs, resulting in cell death. Our results suggest the possibility that autophagy-independent accumulation of pro-LC3 proteins leads to the death of human granulosa cells surrounding the oocytes and presumably reduces oocyte quality and female fertility.
  • Keiichi Yoshida, Woojin Kang, Akihiro Nakamura, Natsuko Kawano, Maito Hanai, Mami Miyado, Yoshitaka Miyamoto, Maki Iwai, Toshio Hamatani, Hidekazu Saito, Kenji Miyado, Akihiro Umezawa
    Reproductive Toxicology 76 71-77 2018年3月1日  査読有り
  • Osamu Inoue, Naoaki Kuji, Hiroe Ito, Mitsutoshi Yamada, Toshio Hamatani, Aimi Oyadomari, Shingo Kato, Hideji Hanabusa, Keiichi Isaka, Mamoru Tanaka
    ASIAN JOURNAL OF ANDROLOGY 19(2) 208-213 2017年3月  査読有り
  • 祝井麻希, 山田満稔, 浜谷敏生
    産科と婦人科 84(3) 309-313 2017年  
  • Kasuga, Y, Nishio, H, Miyakoshi, K, Sato, S, Sugiyama, J, Matsumoto, T, Tanaka, K, Ochiai, D, Minegishi, K, Hamatani, T, Iwata, T, Morisada, T, Nakamura, M, Fujii, T, Kuji, N, Aoki, D, Tanaka, M
    Int J Gynecol Cancer 26(1) 163-168 2016年1月  
    To investigate pregnancy outcomes in women after abdominal radical trachelectomy (RT) for early-stage cervical cancer.|The patients' background, fertility, and pregnancy outcomes were reviewed in a total of 61 pregnancies in 48 of 172 women who underwent abdominal RT at Keio University Hospital between September 2002 and December 2013.|There were 5 women with stage IA1, 2 with stage IA2, and 41 with stage IB1. Histological types were as follows: squamous cell carcinoma (n = 36), adenocarcinoma (n = 10), and adenosquamous cell carcinoma (n = 2). The pregnancy rate of women attempting to conceive after abdominal RT was 44% (48/109). The mean ± SD duration from abdominal RT to conception was 3.1 ± 1.9 years. Of 61 pregnancies, 42 pregnancies were achieved by fertility treatment (in vitro fertilization-embryo transfer, 39; intrauterine insemination, 3). After excluding one pregnancy without detailed clinical information, there were 42 live births (5 in 22-27 weeks, 11 in 28-33weeks, 20 in 34-36 weeks, and 6 in 37-38 weeks), 13 miscarriages, and 5 ongoing pregnancies. While there were 10 first trimester miscarriages, 3 pregnancies ended in the second trimester owing to chorioamnioniti
  • Yamada M, Hamatani T, Akutsu H, Tanaka M
    Journal of Mammalian Ova Research 33(1) 17-34 2016年  査読有り
  • Osamu Inoue, Toshio Hamatani, Nobuyuki Susumu, Wataru Yamagami, Seiji Ogawa, Takashi Takemoto, Akira Hirasawa, Kouji Banno, Naoaki Kuji, Mamoru Tanaka, Daisuke Aoki
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY 14 2 2016年1月  査読有り
  • 安康 真由香, 佐藤 健二, 升田 博隆, 太田 邦明, 佐藤 卓, 内田 浩, 浜谷 敏生, 丸山 哲夫, 末岡 浩, 田中 守
    日本産科婦人科内視鏡学会雑誌 31(Suppl.I) 176-176 2015年8月  
  • Juan J. Tarin, Miguel A. Garcia-Perez, Toshio Hamatani, Antonio Cano
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY 13 1-11 2015年4月  査読有り
  • 上條慎太郎, 浜谷敏生
    HORMONE FRONTIER IN GYNECOLOGY 22(3) 19-28 2015年  
  • 若松修平, 山田満稔, 浜谷敏生
    HORMONE FRONTIER IN GYNECOLOGY 22(1) 25-30 2015年  
  • Tsumura H, Ito M, Takami M, Arai M, Li XK, Hamatani T, Igarashi A, Takada S, Miyado K, Umezawa A, Ito Y
    Biochem Biophys Rep. 5 203-210 2015年  査読有り
  • 安康 真由香, 佐藤 健二, 升田 博隆, 太田 邦明, 宮崎 薫, 小川 誠司, 佐藤 卓, 内田 浩, 浜谷 敏生, 丸山 哲夫, 末岡 浩, 田中 守
    日本生殖医学会雑誌 59(4) 303-303 2014年10月  
  • 太田 邦明, 佐藤 健二, 飯野 孝太郎, 宮崎 薫, 小川 誠司, 佐藤 卓, 升田 博隆, 内田 浩, 浜谷 敏生, 丸山 哲夫, 末岡 浩, 田中 守
    日本生殖医学会雑誌 59(4) 309-309 2014年10月  
  • Mayumi Shoji, Toshio Hamatani, Shoko Ishikawa, Naoaki Kuji, Hiroaki Ohta, Hideo Matsui, Yasunori Yoshimura
    SCIENTIFIC REPORTS 4 5203 2014年6月  査読有り

MISC

 99

講演・口頭発表等

 147

担当経験のある科目(授業)

 6

共同研究・競争的資金等の研究課題

 28